- Home
- About us
- News
- Events
- EXPORT Export
- BUY Buy
- INVEST Invest
- COUNTRY BRAND Country Brand
-
INFORMATION CENTER
Information center
InformationCenterInformationCenterReports Country reports Department reports Foreign trade reports Product-Destination worksheet Sectors reports Work documentsStatistical information Classification Uruguay XXI Exports Imports Innovative National Effort Macroeconomic Monitor Tools Buyers Exporters Investors
- Contact
-
Languages
Uruguay Showcases Biotech Investment Opportunities at Crossing Over LATAM
Uruguay XXI highlighted the country’s potential for investment and growth in life sciences
Share:
Uruguay XXI participated in Crossing Over LATAM BioExpo 2026 to showcase Uruguay as a destination for investment in biotechnology, life sciences, and innovation. Held October 21–23 at the Buenos Aires Convention Center, the event brought together companies, startups, research institutions, investors, and government agencies from across the region.
The agency highlighted Uruguay’s business environment, scientific and technological capabilities, and opportunities to develop high-value projects serving international markets. Cristina Montero, a life sciences specialist on Uruguay XXI’s investment promotion team, emphasized the importance of attracting capital to help technology companies grow and expand their research and development activities.
“Uruguay XXI’s goal is to connect Uruguay’s economy with international markets and attract productive investment that supports development, creates jobs, and improves quality of life for Uruguayans,” Montero said.
Billed as Latin America’s first dedicated biotechnology exhibition and conference, Crossing Over featured talks, panel discussions, scientific presentations, and business meetings. Topics included applications of artificial intelligence in biotechnology, biomanufacturing, sustainability, human health, food and agriculture, and the bioeconomy.
Uruguayan startup Polymera, whose team includes Uruguayan scientists, won the Biotech Startup Award in the event’s startup competition. The recognition put Uruguay’s scientific talent in the spotlight among members of the region’s biotech community.
Montero identified access to funding for later-stage startup growth as a shared challenge across Latin America. She also stressed the importance of securing investment that allows companies to scale while keeping their operations in the region.
“The capital is out there. We want to bring it here so that these startups and companies—and our innovation ecosystems—can grow in Latin America,” she said. She also highlighted the need to attract international investment and encourage local investors to back technology companies.
For Uruguay, these opportunities include attracting new companies and encouraging established businesses to expand their activities in the country. Montero explained that the aim is for companies to use Uruguay as a base for expansion into Latin America and other global markets while also undertaking more research and development locally.
“The goal is always more investment and more technology companies,” she said. Uruguay XXI’s participation in Crossing Over reflected its efforts to connect the country’s scientific and entrepreneurial capabilities with the capital needed to advance life sciences and innovation projects.